Zealand Pharma — December 2021
-
@ungeee helt enig - i begge dele:)
-
smukt - god dag
-
Shortinvestorer skruer op for satsning i Ambu og Zealand
https://www.proinvestor.com/investornyt/747105/shortinvestorer-skruer-op-for-satsning-i-ambu-og-zealand -
Hvis man tror på at Glepaglutide mod SBS kommer med gode data i 2022 så er Zealand P. godt nok ved at se billig ud. Hvis man tror på både gode Glapaglutide data og at Zealogue salget kommer op på et acceptabelt niveau i 2022 så
er Zealand P ved at se rigtig rigtig billig ud (-: -
Zealand Pharma Announces Seven-Year, $200 Million Financing Agreement with Oberland Capital
Zealand Pharma Announces Seven-Year, $200 Million Financing Agreement with Oberland Capital
Company announcement – No. 75 / 2021 Zealand Pharma Announces Seven-Year, $200 Million Financing Agreement with Oberland Capital Agreement includes an...
GlobeNewswire News Room (www.globenewswire.com)
-
Agreement includes an upfront payment of $100 million in exchange for a 7-year, interest-only secured note
The non-dilutive debt facility will support continued development of clinical pipeline, including additional indications for dasiglucagon and glepaglutide, as well as earlier stage pipeline investigating unmet needs in obesity and inflammatory diseases
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind